Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Come clean, avoid the consequences. The Trump administration is launching a six-month pilot program allowing healthcare companies to voluntarily self-disclose False Claims Act (FCA) violations in exchange for significant legal and regulatory relief. Companies that participate can avoid exclusion from federal programs, corporate integrity agreements, and civil monetary penalties — as long as they fully cooperate and repay the government.
Come clean, avoid the consequences. The Trump administration, through a joint HHS and DOJ initiative, is rolling out a six-month pilot program that gives healthcare companies a structured path to voluntarily self-disclose potential civil False Claims Act (FCA) violations. In return for full transparency and repayment, participating companies receive substantial protections — including a DOJ release from FCA liability and freedom from exclusion, corporate integrity agreements, civil monetary penalties, and CMS enrollment or billing privilege revocations.
To qualify, companies must disclose all relevant details and documents, outline remediation steps already taken, and make a repayment calculated under the pilot's terms. The repayment multiplier is shaped by factors like the violation's duration and scope, timeliness of disclosure, senior leadership involvement, and financial benefit gained.
Key Takeaways:
Why it matters: For healthcare organizations navigating compliance risk, this pilot offers a rare opportunity to resolve past missteps with reduced legal exposure — while the government gets faster recoveries and can redirect enforcement resources toward deliberate bad actors.
